BioCryst Pharmaceuticals
BCRX
#4770
Rank
โ‚ฌ1.50 B
Marketcap
7,27ย โ‚ฌ
Share price
1.47%
Change (1 day)
43.73%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2023 (TTM): -1,16ย โ‚ฌ

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -1,20ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,27ย โ‚ฌ a decrease over its 2021 EPS that were of -0,99ย โ‚ฌ.

EPS history for BioCryst Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,16ย โ‚ฌ-9%
2022-1,27ย โ‚ฌ29.13%
2021-0,99ย โ‚ฌ-4.63%
2020-1,03ย โ‚ฌ10.2%
2019-0,94ย โ‚ฌ0%
2018-0,94ย โ‚ฌ25.64%
2017-0,75ย โ‚ฌ4%
2016-0,72ย โ‚ฌ27.12%
2015-0,56ย โ‚ฌ-13.24%
2014-0,65ย โ‚ฌ23.64%
2013-0,53ย โ‚ฌ-30.38%
2012-0,76ย โ‚ฌ-37.3%
2011-1,21ย โ‚ฌ65.79%
2010-0,73ย โ‚ฌ117.14%
2009-0,34ย โ‚ฌ-46.15%
2008-0,62ย โ‚ฌ-26.97%
2007-0,85ย โ‚ฌ-40.67%
2006-1,44ย โ‚ฌ48.51%
2005-0,97ย โ‚ฌ1%
2004-0,96ย โ‚ฌ38.89%
2003-0,69ย โ‚ฌ-25%
2002-0,92ย โ‚ฌ231.03%
2001-0,28ย โ‚ฌ-56.72%
2000-0,64ย โ‚ฌ117.44%
1999-0,29ย โ‚ฌ2.94%
1998-0,29ย โ‚ฌ-55.84%
1997-0,65ย โ‚ฌ11.59%
1996-0,58ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
2,00ย โ‚ฌ-267.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-7,49ย โ‚ฌ 526.40%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,56ย โ‚ฌ-52.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-6,88ย โ‚ฌ 475.20%๐Ÿ‡บ๐Ÿ‡ธ USA
4,20ย โ‚ฌ-451.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-2,30ย โ‚ฌ 92.00%๐Ÿ‡บ๐Ÿ‡ธ USA
3,35ย โ‚ฌ-380.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
-11,56ย โ‚ฌ 866.40%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,74ย โ‚ฌ-38.40%๐Ÿ‡บ๐Ÿ‡ธ USA